Abstract

A substantial amount of data suggests that both RNA and DNA tumor viruses are associated with human cancer. Correction of malignant transformation at the genotypic level may be possible in the future but will require significant advances in our understanding of genomic material. The use of simple defined models such as tumor viruses seems like a reasonable place to start. The use of antipromotors (e.g. retinoids) and inhibitors of promotors will prove as important to the successful treatment of cancer in the next decade as chemotherapy has been in the last two decades.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.